Literature DB >> 35146290

Experiences from the Department of Infectious Disease Epidemiology at Robert Koch Institute.

Thomas Harder1.   

Abstract

Entities:  

Year:  2020        PMID: 35146290      PMCID: PMC8734186          DOI: 10.25646/6506

Source DB:  PubMed          Journal:  J Health Monit        ISSN: 2511-2708


× No keyword cloud information.
At Robert Koch Institute’s Department of Infectious Disease Epidemiology, approaches for applying the principles of evidence-based public health (EBPH) have been particularly successfully implemented in the Immunization Unit and in the Unit for Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption. Furthermore, both units participated in the international Project on a Framework for Rating Evidence in Public Health (PRECEPT) which has been funded by the European Centre for Disease Prevention and Control (ECDC). The Immunization Unit hosts the Executive Secretariat of the German Standing Committee on Vaccination (STIKO). In 2011, STIKO has adopted a new Standard Operating Procedure (SOP) for the development of vaccination recommendations. Main aim was to provide a methodological framework to guide this process by applying the principles of EBPH. The SOP comprises ten consecutive steps, starting with a prioritization process of relevant topics, and ending with the publication of the recommendation and a related paper on the scientific background. Following the principles of EBPH, systematic reviews and meta-analyses are performed to address key issues. The methodology of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group is a core element of the SOP and is used to assess the quality of evidence on vaccine efficacy/effectiveness and safety, including population effects. In addition, STIKO has started to use Evidence-to-Decision Tables to support the decision-making process. Since 2012, ten recommendations on new vaccines or revisions of previous recommendations have been successfully developed using the SOP, accompanied by publication of background papers and of the respective systematic reviews in peer-reviewed journals [1-3]. At the Unit for Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, the EBPH approach has been used to perform systematic reviews on the burden of healthcare-associated infections [4]. As an example, in an ECDC-funded project the long-term consequences of health-care-acquired neonatal sepsis for the neurological development of preterm infants were assessed by meta-analysis [5]. Furthermore, a systematic review addressed the prognostic value of neonatal surface screening for gram-negative bacteria for sepsis prediction [6]. The latter review was part of the PRECEPT project. PRECEPT defined a methodology for evaluating and grading evidence in public health, with a particular focus on infectious disease epidemiology, prevention and control, taking different domains and question types into consideration [7]. The methodology rates evidence in four domains: disease burden, risk factors, diagnostics and intervention. The framework has four steps going from overarching questions to an evidence statement. In step 1, approaches for identifying key areas and developing specific questions are described. In step 2, methodological guidance for conducting systematic reviews is provided. In step 3, a standardized evidence-grading scheme using the GRADE methodology is provided. Step 4 consists of preparing a narrative evidence summary. The development of the approach was accompanied by piloting studies as well as studies on method ological aspects such as choice of risk of bias tools and use of existing systematic reviews for development of new recommendations [8, 9]. Dissemination of the PRECEPT approach was supported by the development of an e-learning tool hosted by ECDC.
  9 in total

Review 1.  Routine screening for colonization by Gram-negative bacteria in neonates at intensive care units for the prediction of sepsis: systematic review and meta-analysis.

Authors:  J Seidel; S Haller; T Eckmanns; T Harder
Journal:  J Hosp Infect       Date:  2018-03-22       Impact factor: 3.926

Review 2.  Neurological sequelae of healthcare-associated sepsis in very-low-birthweight infants: Umbrella review and evidence-based outcome tree.

Authors:  Sebastian Haller; Philipp Deindl; Alessandro Cassini; Carl Suetens; Walter Zingg; Muna Abu Sin; Edward Velasco; Bettina Weiss; Tanja Ducomble; Madlen Sixtensson; Tim Eckmanns; Thomas Harder
Journal:  Euro Surveill       Date:  2016

Review 3.  The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.

Authors:  Yvonne Deleré; Ole Wichmann; Stefanie J Klug; Marianne van der Sande; Martin Terhardt; Fred Zepp; Thomas Harder
Journal:  Dtsch Arztebl Int       Date:  2014-09-01       Impact factor: 5.594

Review 4.  Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.

Authors:  Gerhard Falkenhorst; Cornelius Remschmidt; Thomas Harder; Eva Hummers-Pradier; Ole Wichmann; Christian Bogdan
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 5.  Use of existing systematic reviews for evidence assessments in infectious disease prevention: a comparative case study.

Authors:  Thomas Harder; Cornelius Remschmidt; Sebastian Haller; Tim Eckmanns; Ole Wichmann
Journal:  Syst Rev       Date:  2016-10-11

6.  Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools.

Authors:  Thomas Harder; Anja Takla; Eva Rehfuess; Alex Sánchez-Vivar; Dorothea Matysiak-Klose; Tim Eckmanns; Gérard Krause; Helena de Carvalho Gomes; Andreas Jansen; Simon Ellis; Frode Forland; Roberta James; Joerg J Meerpohl; Antony Morgan; Holger Schünemann; Teun Zuiderent-Jerak; Ole Wichmann
Journal:  BMC Med Res Methodol       Date:  2014-05-21       Impact factor: 4.615

7.  Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.

Authors:  Alessandro Cassini; Diamantis Plachouras; Tim Eckmanns; Muna Abu Sin; Hans-Peter Blank; Tanja Ducomble; Sebastian Haller; Thomas Harder; Anja Klingeberg; Madlen Sixtensson; Edward Velasco; Bettina Weiß; Piotr Kramarz; Dominique L Monnet; Mirjam E Kretzschmar; Carl Suetens
Journal:  PLoS Med       Date:  2016-10-18       Impact factor: 11.069

8.  PRECEPT: an evidence assessment framework for infectious disease epidemiology, prevention and control.

Authors:  Thomas Harder; Anja Takla; Tim Eckmanns; Simon Ellis; Frode Forland; Roberta James; Joerg J Meerpohl; Antony Morgan; Eva Rehfuess; Holger Schünemann; Teun Zuiderent-Jerak; Helena de Carvalho Gomes; Ole Wichmann
Journal:  Euro Surveill       Date:  2017-10

Review 9.  Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

Authors:  Thomas Harder; Ole Wichmann; Stefanie J Klug; Marianne A B van der Sande; Miriam Wiese-Posselt
Journal:  BMC Med       Date:  2018-07-18       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.